Organ Preservation Solutions Market Size Will Projected to Reach US$498.3 Million by 2027 with a 10.5% CAGR | TMR Analysis

The global organ preservation solutions market, valued at US$193.4 million in 2018, is poised for significant growth over the forecast period. It is projected to expand at a robust compound annual growth rate (CAGR) of 10.5% from 2019 to 2027, reaching US$498.3 million by the end of 2027. This dynamic expansion reflects the increasing demand for organ transplantation and advanced preservation techniques, driven by rising organ failure rates, technological advancements in preservation solutions, and growing transplant programs worldwide. As healthcare systems prioritize life-saving transplant procedures, the market is set to more than double in value, reinforcing its critical role in transplant medicine through 2027.

Get Sample PDF Brochure from here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1786

Understanding the Organ Preservation Solutions Market

Organ preservation solutions are specialized fluids used to maintain the viability of organs during transportation and storage prior to transplantation. These solutions, such as University of Wisconsin (UW) solution, Custodiol HTK, and Perfadex, prevent cellular damage by providing optimal conditions for organs like kidneys, livers, and hearts. The 2018 valuation of US$193.4 million underscores its established importance, with the projected rise to US$498.3 million by 2027 highlighting its response to the growing global transplant demand.

The 10.5% CAGR signals a vibrant growth phase, fueled by clinical advancements and transplant needs. The market's momentum is driven by its essential role in improving transplant success rates.

Key Drivers of Market Growth

Several factors are propelling the organ preservation solutions market toward its US$498.3 million milestone by 2027. First, the rising prevalence of organ failure is a primary driver. Chronic diseases like diabetes and hypertension contribute to kidney and liver failure, with over 700,000 end-stage renal disease cases annually, per WHO estimates. The growing transplant waiting lists-over 150,000 in the U.S. alone-align with the 10.5% CAGR, boosting demand for effective preservation solutions.

Second, technological advancements in preservation techniques are accelerating growth. Innovations like hypothermic machine perfusion (HMP) and normothermic perfusion extend organ viability compared to traditional static cold storage. Solutions like Perfadex, optimized for lungs, improve outcomes, driving the market toward US$498.3 million by enabling the use of marginal donor organs.

Third, expanding transplant programs and healthcare infrastructure are boosting the market. Government initiatives, such as India's National Organ Transplant Programme, and increased funding for transplant centers in developed nations enhance access. Rising organ donation awareness, supported by organizations like UNOS, reinforces the market's trajectory through 2027.

Leading Players:

Dr. Franz Köhler Chemie GmbH
Bristol-Myers Squibb Company
Teva Pharmaceutical Industries Ltd
XVIVO Perfusion AB
BioLife Solutions, Inc.
21st Century Medicine
Bridge to Life Ltd.
Accord Healthcare
OrganOx Limited,

Visit our report to discover essential insights and analysis - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1786

Market Segmentation and Regional Insights

The market segments by solution type, preservation technique, and geography. UW solution dominates due to its widespread use in kidney and liver preservation, followed by Custodiol HTK for heart and Perfadex for lungs. Static cold storage leads preservation techniques for its cost-effectiveness, but machine perfusion is growing rapidly. Applications include kidney, liver, heart, and lung transplants, with kidneys leading due to high transplant volumes.

Regionally, North America held a significant share of the US$193.4 million valuation in 2018, driven by advanced transplant infrastructure, high organ failure rates, and robust R&D in the United States. Europe followed, with strong markets in Germany and the UK, supported by well-established transplant networks. The Asia-Pacific region is expected to see the fastest growth through 2027, fueled by rising chronic diseases, expanding transplant programs, and healthcare investments in China and India.

Challenges and Opportunities

The market faces challenges. High costs of advanced preservation systems, like HMP devices (tens of thousands per unit), limit adoption in developing regions. Shortages of donor organs and variability in solution efficacy for different organs pose barriers. Regulatory complexities for new solutions also delay approvals. The 10.5% CAGR reflects a market navigating these hurdles with strong growth potential.

These challenges present opportunities. Developing cost-effective perfusion systems or universal preservation solutions could broaden access, supporting the push to US$498.3 million. Innovations in ex-vivo organ conditioning and bioengineered solutions offer growth potential, while organ donation campaigns in emerging markets could exceed projections. Partnerships with transplant organizations to standardize protocols could further enhance growth.

The Road to 2027

By 2027, the global organ preservation solutions market is projected to reach US$498.3 million, reflecting nine years of robust growth at a 10.5% CAGR from US$193.4 million in 2018. This milestone is driven by transplant demand, technological innovation, and global healthcare advancements. As the forecast concludes, the market's trajectory suggests continued expansion, with potential for advanced preservation to transform transplantation.

In conclusion, the organ preservation solutions market demonstrates remarkable growth from 2019 to 2027. Rising from US$193.4 million to US$498.3 million, it addresses critical transplant needs with innovative solutions. Stakeholders-from solution manufacturers to transplant surgeons-play a vital role in this success, ensuring viable organs save lives worldwide through 2027 and beyond.

Explore Latest Research Reports by Transparency Market Research:

Pharma 4.0 Market: https://www.pharmiweb.com/press-release/2025-03-18/pharma-40-market-size-will-estimated-to-grow-at-a-cagr-of-177-by-2035-driven-by-digital-transformation-in-drug-manufacturing-exclusive-report-by

Dialysis Equipment Market: https://www.pharmiweb.com/press-release/2025-03-18/dialysis-equipment-market-poised-to-surpass-us-252-bn-by-2035-amidst-rising-ckd-cases-and-technological-advancements-tmr-insights

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com

This release was published on openPR.